Explains why GSK were so willing to share trial results for relenza and why Roche were not so forthcoming?http://www.6minutes.com.au/news/latest-news/unpublished-studies-show-tamiflu-doesn-t-work
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint